By analysing PanCancer genomic data, we then asked whether PLCD4, PLCB4 and PLD3 levels correlate to the pathogenesis of human pancreatic ductal carcinoma. This evidence concerns the gene PLCB4 and pancreatic ductal adenocarcinoma.